Lanreotide as Treatment of Polycystic Livers

Inclusion Criteria: * 18 yrs-of age * Multiple cysts \> 20 * Cooperating patient * Is willing and able to comply with the study drug regimen and all other study requirements * Willingness to give written informed consent Exclusion Criteria: * Use of oral anticonceptives or estrogen suppletion * Females who are pregnant or breast-feeding * History or other evidence of chronic pulmonary disease associated with functional limitation * History of severe cardiac disease * History or other evidence of severe illness or any other conditions which would make the patient, in the opinion of the investigator, unsuitable for the study * Symptomatic gallstones * Renal failure requiring hemodialysis